Jolie M. Siegel


Jolie joined C4 Therapeutics in 2020 as the company’s Chief Legal Officer and is responsible for all aspects of C4T’s legal and intellectual property matters. Prior to joining, Jolie served as General Counsel and Secretary at Neon Therapeutics (Nasdaq: NTGN), an immune oncology company focused on developing personalized cancer vaccines and T cell therapies, a role she held through the sale of Neon to BioNTech SE (Nasdaq: BNTX) in May 2020. Prior to Neon, Jolie was the Senior Vice President, Deputy General Counsel and Assistant Secretary of Intralinks (NYSE: IL), a financial technology provider for the global banking, deal making and capital markets communities, a role she held through the sale of the company in 2017.

Prior to her time in-house, Jolie was a partner at Choate, Hall & Stewart LLP where she worked on corporate transactional, securities and general business matters, with an emphasis on private equity, venture capital and high-growth companies in life sciences and a range of other industries. Jolie started her legal career at Testa, Hurwitz & Thibeault, LLP where she was a member of the business practice group.

Jolie holds a J.D. from the University of Pennsylvania Law School and a B.A., cum laude, from the University of Pennsylvania.